224 related articles for article (PubMed ID: 23438961)
1. Importance of receptor-targeted systems in the battle against atherosclerosis.
Rosas E; Sobenin I; Orekhov A; Edelman ER; Balcells M
Curr Pharm Des; 2013; 19(33):5897-903. PubMed ID: 23438961
[TBL] [Abstract][Full Text] [Related]
2. Cyclophilins in atherosclerosis: a new therapeutic target?
Bukrinsky M; Orekhov A; Ditiatkovski M; Sviridov D
Curr Pharm Des; 2013; 19(33):5904-8. PubMed ID: 23438962
[TBL] [Abstract][Full Text] [Related]
3. Cell adhesion molecule-mediated therapeutic strategies in atherosclerosis: From a biological basis and molecular mechanism to drug delivery nanosystems.
Yin M; Li C; Jiang J; Le J; Luo B; Yang F; Fang Y; Yang M; Deng Z; Ni W; Shao J
Biochem Pharmacol; 2021 Apr; 186():114471. PubMed ID: 33587918
[TBL] [Abstract][Full Text] [Related]
4. Emerging anti-inflammatory therapies for atherosclerosis.
Roubille F; Kritikou EA; Roubille C; Tardif JC
Curr Pharm Des; 2013; 19(33):5840-9. PubMed ID: 23438958
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelium and atherosclerosis.
Libby P; Aikawa M; Jain MK
Handb Exp Pharmacol; 2006; (176 Pt 2):285-306. PubMed ID: 16999230
[TBL] [Abstract][Full Text] [Related]
6. Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.
Ramji DP; Davies TS
Cytokine Growth Factor Rev; 2015 Dec; 26(6):673-85. PubMed ID: 26005197
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell-selective adhesion molecule modulates atherosclerosis through plaque angiogenesis and monocyte-endothelial interaction.
Inoue M; Ishida T; Yasuda T; Toh R; Hara T; Cangara HM; Rikitake Y; Taira K; Sun L; Kundu RK; Quertermous T; Hirata K
Microvasc Res; 2010 Sep; 80(2):179-87. PubMed ID: 20406651
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in pro-atherosclerotic arterial remodeling.
Myasoedova VA; Chistiakov DA; Grechko AV; Orekhov AN
J Mol Cell Cardiol; 2018 Oct; 123():159-167. PubMed ID: 30172754
[TBL] [Abstract][Full Text] [Related]
9. Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic Approaches.
Park KH; Park WJ
J Korean Med Sci; 2015 Sep; 30(9):1213-25. PubMed ID: 26339159
[TBL] [Abstract][Full Text] [Related]
10. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
[TBL] [Abstract][Full Text] [Related]
11. Protective Effect of Epigallocatechin Gallate on Endothelial Disorders in Atherosclerosis.
Yamagata K
J Cardiovasc Pharmacol; 2020 Apr; 75(4):292-298. PubMed ID: 31895874
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties.
Khanicheh E; Qi Y; Xie A; Mitterhuber M; Xu L; Mochizuki M; Daali Y; Jaquet V; Krause KH; Ruggeri ZM; Kuster GM; Lindner JR; Kaufmann BA
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2187-92. PubMed ID: 23908248
[TBL] [Abstract][Full Text] [Related]
13. Advances in imaging angiogenesis and inflammation in atherosclerosis.
Zagorchev L; Mulligan-Kehoe MJ
Thromb Haemost; 2011 May; 105(5):820-7. PubMed ID: 21331441
[TBL] [Abstract][Full Text] [Related]
14. The Inhibitory Effect of Ojeoksan on Early and Advanced Atherosclerosis.
Han BH; Seo CS; Yoon JJ; Kim HY; Ahn YM; Eun SY; Hong MH; Lee JG; Shin HK; Lee HS; Lee YJ; Kang DG
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30200674
[TBL] [Abstract][Full Text] [Related]
15. Non-Invasive Detection of Extracellular Matrix Metalloproteinase Inducer EMMPRIN, a New Therapeutic Target against Atherosclerosis, Inhibited by Endothelial Nitric Oxide.
Ramirez-Carracedo R; Tesoro L; Hernandez I; Diez-Mata J; Filice M; Toro R; Rodriguez-Piñero M; Zamorano JL; Saura M; Zaragoza C
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347750
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory mediators of endothelial injury in sickle cell disease.
Hoppe CC
Hematol Oncol Clin North Am; 2014 Apr; 28(2):265-86. PubMed ID: 24589266
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell biology, perivascular inflammation, and vasculitis.
Cid MC
Cleve Clin J Med; 2002; 69 Suppl 2():SII45-9. PubMed ID: 12086264
[No Abstract] [Full Text] [Related]
18. Cytokines and adhesive molecules in detection of endothelial dysfunction.
Mizia-Stec K
Pharmacol Rep; 2006; 58 Suppl():21-32. PubMed ID: 17332668
[TBL] [Abstract][Full Text] [Related]
19. Cell adhesion molecules as pharmaceutical target in atherosclerosis.
Ling S; Nheu L; Komesaroff PA
Mini Rev Med Chem; 2012 Feb; 12(2):175-83. PubMed ID: 22070689
[TBL] [Abstract][Full Text] [Related]
20. Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability.
Ruddy JM; Ikonomidis JS; Jones JA
J Vasc Res; 2016; 53(1-2):1-16. PubMed ID: 27327039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
